Ingredion (NYSE:INGR) Cut to “Strong Sell” at Zacks Research

Ingredion (NYSE:INGR) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Tuesday,Zacks.com reports.

Several other research firms have also commented on INGR. Oppenheimer dropped their price target on shares of Ingredion from $130.00 to $126.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group restated a “hold” rating on shares of Ingredion in a research report on Wednesday, February 4th. BMO Capital Markets restated a “market perform” rating on shares of Ingredion in a research report on Wednesday, February 4th. Barclays dropped their price target on shares of Ingredion from $128.00 to $120.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 6th. Finally, Stephens restated an “equal weight” rating and set a $120.00 price target on shares of Ingredion in a research report on Wednesday, February 4th. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $122.43.

Ingredion Stock Up 0.3%

INGR stock opened at $100.61 on Tuesday. The firm has a market cap of $6.34 billion, a PE ratio of 9.69, a P/E/G ratio of 0.84 and a beta of 0.64. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.83 and a current ratio of 2.76. The firm’s fifty day moving average is $110.60 and its 200 day moving average is $111.95. Ingredion has a one year low of $99.50 and a one year high of $140.85.

Ingredion (NYSE:INGR) last released its quarterly earnings results on Tuesday, May 5th. The company reported $2.34 EPS for the quarter, missing the consensus estimate of $2.44 by ($0.10). The firm had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.79 billion. Ingredion had a net margin of 9.36% and a return on equity of 15.86%. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.97 EPS. Ingredion has set its FY 2026 guidance at 10.450-11.150 EPS. On average, research analysts forecast that Ingredion will post 10.88 EPS for the current year.

Insider Activity

In other news, VP Davida Marie Gable sold 375 shares of Ingredion stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $112.44, for a total value of $42,165.00. Following the sale, the vice president owned 7,110 shares in the company, valued at $799,448.40. This trade represents a 5.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Ingredion

A number of hedge funds have recently modified their holdings of INGR. International Assets Investment Management LLC acquired a new stake in shares of Ingredion in the fourth quarter valued at about $30,000. GHP Investment Advisors Inc. acquired a new position in Ingredion during the first quarter worth about $33,000. Root Financial Partners LLC acquired a new position in Ingredion during the third quarter worth about $36,000. Los Angeles Capital Management LLC acquired a new position in Ingredion during the fourth quarter worth about $36,000. Finally, Capital Advisors Ltd. LLC boosted its position in Ingredion by 40.5% during the fourth quarter. Capital Advisors Ltd. LLC now owns 354 shares of the company’s stock worth $39,000 after acquiring an additional 102 shares during the last quarter. 85.27% of the stock is currently owned by institutional investors and hedge funds.

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.